Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by ...
Jul 9, 2012
2
0
Two clinical trials led by Johns Hopkins Kimmel Cancer Center researchers in collaboration with other medical centers, testing experimental drugs aimed at restoring the immune system's ability to spot and attack cancer, have ...
Jun 2, 2012
0
0
PD-L1 checkpoint inhibitors are a powerful and growing form of immunotherapy used to treat melanoma, kidney cancer, head and neck cancers, Hodgkin's lymphoma and other cancers. The PD-L1 protein is expressed on tumor cells ...
Jul 26, 2019
1
128
The kidneys often become bulky and dysfunctional in diabetes, and now scientists have found that one path to this damage dramatically reduces the kidney's ability to clean up after itself.
Sep 22, 2020
0
114
Researchers at Memorial Sloan Kettering Cancer Center, New York, have concluded their phase 2 trial of chemotherapy in combination with the drugs nivolumab, and regorafenib.
If kidney cancer is diagnosed early—before it spreads—80 percent of patients survive. However, finding it early has been among the disease's greatest challenges.
Mar 19, 2015
0
183
(HealthDay)—Patients with nonfunctional adrenal tumors (NFATs) have increased risk of diabetes compared to those without adrenal tumors, according to a study published online Aug. 2 in the Annals of Internal Medicine.
Aug 4, 2016
0
1
BGI, the world's largest genomics organization, developed single-cell genome sequencing technology and published two research papers for cancer single-cell sequencing in the research journal Cell. In the papers, which were ...
Mar 2, 2012
0
0
(Medical Xpress) -- When considering treatment options for kidney tumors, preserving any kidney function is preferable to removing the entire organ: Cardiovascular health improves, hypertension is less frequent and re-hospitalization ...
Jun 17, 2011
0
0
A newly developed small-molecular radiopharmaceutical pair has successfully visualized and treated melanoma in a preclinical study, according to new research presented at the Society of Nuclear Medicine and Molecular Imaging ...
Jun 15, 2022
0
8
